Michele Madonna Lindsey, a bipolar manic depressive, discusses what it takes to cope with the mental illness.
I was diagnosed with bipolar disorder when I was 16, and I'm now 18 and it has gotten where I can't even get a job because I stress myself out so much that I can't even think straight. I've been on Zoloft, Prozac, Lexapro, and Seroquel but nothing has helped me get over this. I feel like every time I try to do something a switch comes on in my head, and I get in fight-or-flight mode, and I usually flee. My sleeping patterns are also irregular. If anyone has some suggestions for me I would greatly appreciate it.
The FAA is changing its policy to allow pilots using anti-depressants to fly again. CNN's Jeanne Meserve reports.
Two years ago, in perhaps the hardest decision of his life, an Oklahoma charter jet pilot stopped flying because he was suffering from depression. Embarrassed, he kept the reasons for leaving his career hidden from all but his closest confidants.
The FAA's Randy Babbitt says the agency is dropping its ban on pilots using Prozac and three other anti-depressants.
Budget and tax experts are a despondent bunch these days. In fact, some have even described themselves to CNNMoney as "depressed."
The father's first comment, when he heard I was in his city to talk about a book I'd written about kids, mental health issues and medication, came loudly and fast: "When my daughter was 10, my ex-wife and a psychiatrist called to try to get my permission to put her on Prozac. I refused," he said proudly. "I wasn't going to let them drug my kid."
People who take antidepressants such as Paxil often say they feel less stressed and more outgoing, lively, and confident. Now a new study suggests it's not just because they're less depressed.
Can a stimulant medication for ADHD make the child taking it have mood swings and violent aggression?
My head is all static like a TV not turned to any working channel. There is a sadness in me that crawls up from my stomach and out my throat and screams so loud my ears bleed from it. I feel emptiness. I feel a great swallowing hole at my center. I feel pain twisting in like glass spirals. I feel leeches sucking at my spine -- around my rib cage -- at the backs of my eyes. I feel it come on me for no reason -- for no reason at all. I'll be at the beach with my dog and my girlfriend and we'll be walking there as the sun is setting and the sky is smudged with toxic colors. The wind will be blowing and there'll be nothing I have to do but go get something to eat and maybe watch a movie, or something but, still, out of nowhere, the darkness will come up on me, grab me by the throat, tighten, pull me down, down, f---ing down. It's this grave opened up for me -- this tomb that closes around me and is cemented solid shut. My voice is silenced. I curl into myself, fetus style, shrinking
I have been treated for depression since I was 8, and I am now 30. I have tried numerous medications along with a ton of therapy. I am also a recovering alcoholic who is working the AA program. My problem lies in the fact that I am extremely sensitive to medications and of the 30+, I still have yet to find something that actually works. Lexapro seemed to work for a while, but I changed due to the sexual side effects being a problem. When I tried to restart taking it, I was overcome with anxiety. I was also taking 50mg of Serzone if that makes any difference. I am currently taking Prozac-5mg, Serzone -50mg, and Klonopin as needed (reluctantly, I might add). I am hesitant to try electroconvulsive treatment, but I am at a point where I am desperate. The depression interferes with every aspect of my life and makes it difficult to fully live. I feel as if I am merely surviving in this world. I don't know what else I can do. Do you have ANY suggestions? I have a great therapist, doctor and
What is fibromyalgia? What causes fibromyalgia? Can it effectively be treated without prescription drugs? What is the difference between gabapentin and Cymbalta?
Is it OK to take antidepressants while pregnant?
We've reached a dubious health milestone: More than half of insured Americans are now taking at least one "maintenance" drug for a chronic condition, according to a recent health industry report.
When surfing the Internet for safe Web sites, not all domains are equal
Consultations: TIME asks a prominent bioethicist whether antidepressants should be more widely available
Nancy Fitzpatrick tells her brother, CNN's David Fitzpatrick, why she tried to commit suicide with pills bought online.
She found her husband on their bed in a pool of his own vomit, dead from an accidental overdose of drugs he received from an online pharmacy.
Memo to the market gods: I can't take it anymore. One day fear of recession tanks stocks. The next day it's inflation or a collapsing investment bank. Frankly, the market needs Prozac.
The building where a gunman killed five people at Northern Illinois University two weeks ago will be demolished, state officials said Wednesday.
The likes of Prozac and Paxil have little impact on most patients, according to a new study
The man who killed several students at Northern Illinois University had asked his godfather for help choosing weapons.
The revelation from Steven Kazmierczak's girlfriend that he had stopped taking an antidepressant a few weeks before his rampage at Northern Illinois University has reopened debate about whether the drug can cause violent behavior.
A British researcher thinks January holds the saddest day of the year, but Hitwise says November is more depressing
Given the pervasive gloom in the face of the housing slump and sudden sharp drops in stock prices earlier this year, you might have figured it was just a matter of time before the economy would collapse faster than the Colorado Rockies in the World Series. In fact, a survey last summer found that two-thirds of Americans believed the economy either was already in a recession or would be in the next year.
Kevin Gyateng of Corporate FX joins CNN to discuss the impact of the federal interest rate cuts.
It's all about the people: I've had a blockbuster couple of weeks running around all over the place sitting down with all kinds of cool people. Sometimes when I mention I've met so-and-so, folks write in and say: 'Stop name-dropping and tell what these people are saying!"
Thanks to a history of bad reactions, Louanne Weston was willing to do almost anything to avoid anesthesia. So when her doctor advised surgery to remove uterine fibroids that were causing cramps and heavy bleeding, Weston went looking for an anesthesia alternative. She found hypnosis -- and her doctor agreed to give it a try.
Eli Lilly & Co. sued Barr Pharmaceuticals, a maker of generic drugs, for patent infringement over the antidepressant Prozac Weekly, said the companies on Thursday.
Zoloft, the antidepressant with the household name, is going off patent this summer, forcing Pfizer to bid adieu to billions of dollars in annual sales.
Can Prozac make you want to die? The idea seems strange, given that the drug and similar antidepressants are supposed to do just the opposite. Yet that is what Kimberly Witczak believes happened to...
Over more than a century, in roughly 30-year cycles, psychiatry has embraced one popular class of drugs after another to treat mental illness. At first, they have seemed to be miracle workers--but ...
A case wending its way through the courts could put antidepressants like Prozac and Zoloft under an even bigger cloud -- and cost their makers even more money.
The package claims that the three-disc set includes ''Our National Anthem sung in 4-correspondent harmony.''
Pssst! Want some Viagra? How about Xanax? Prozac?
Drugmakers rue the day when patents expire on blockbuster products, but some companies have found ways to relieve the pain of patent loss and wring more sales out of name brands.
Each year the Hollywood studios send out a calendar of releases.
The Food and Drug Administration has backed off its warning that antidepressants such as Zoloft, Paxil and Prozac can cause suicidal actions among children and teens taking those prescription drugs.
A British medical journal has retracted an article and apologized for claiming that internal industry documents it received from an anonymous source had gone "missing" during a 1994 product liability suit against the maker of Prozac.
The medical journal BMJ Thursday retracted and apologized for the claim it made early this month that internal industry documents it received from an anonymous source had gone "missing" during a 1994 product liability suit against Eli Lilly and Co., maker of the antidepressant Prozac.
Internal documents from Eli Lilly and Co. appear to indicate that the drug maker had data more than 15 years ago showing that adverse-effect reports for Prozac were far more likely to list suicide attempts and violence than reports for other antidepressants.
An internal document purportedly from Eli Lilly and Co. appears to show that the drug manufacturer had data more than 15 years ago showing that patients on its antidepressant Prozac were far more likely to attempt suicide and show hostility than patients on other antidepressants.
An internal document purportedly from Eli Lilly and Co. made public Monday appears to show that the drug maker had data more than 15 years ago showing that patients on its antidepressant Prozac were far more likely to attempt suicide and show hostility than were patients on other antidepressants and that the company attempted to minimize public awareness of the side effects.
Wall Street ended an upbeat year not with a bang, but a whimper, in quiet New Year's trading Friday.
Despite a see-saw performance during the final trading week of 2004, the Dow Jones industrial average and the tech-heavy Nasdaq-100 are both likely to log gains for the year that end Friday.
Ever since September 2003—when New York State attorney general Eliot Spitzer exposed chronic corruption in the mutual fund business—legislators, regulators and the media have been spewing out plans...
Ever since September 2003 -- when New York State attorney general Eliot Spitzer exposed chronic corruption in the mutual fund business -- legislators, regulators and the media have been spewing out plans to fix the way that funds are run.
In business, as in life, there's no such thing as a perfect plan. So you can imagine how Eli Lilly's chief executive, Sidney Taurel, feels as he surveys the jagged urban terrain of Indianapolis fro...
Eli Lilly's flagging sales of Prozac could receive an un-expected boost this year. Anti-depressants, those wonder drugs of the '80s and '90s, are increasingly under attack amid questions about the...
They call it "the invisible illness," and for good reason: Depression affects nearly one in 10 U.S. adults each year, but experts say the disease is treatable in most cases.
Science geeks may debate the exact beginning of the New Millennium. Was it Jan. 1, 2000, or a year later, in 2001? Drug company investors, though, have no doubt when the new era commenced. On the f...
You hate the way you feel. A dark cloud hangs over you, blotting out the sunlight. There's no escape, no hope. You're used to handling stress, but this is different; it's out of your control. Ask a...
Grand investment trends often start with a bang. The OPEC oil embargo fueled the hydrocarbon run of the 1970s. Reagan-era tax cuts kicked off the 1980s rush to consumer products stocks. The Interne...
Your boss has stopped saying hello in the morning. One of your underlings now goes to the weekly meeting that you're no longer invited to. Everybody at the office is looking tanned, fit, and rel...
The collapse of tech stocks since March 2000 has been so devastating that lesser disasters aren't getting the attention they deserve. Pharmaceutical giants were premier growth stocks throughout mos...
The collapse of tech stocks since March 2000 has been so devastating that lesser disasters aren't getting the attention they deserve. Pharmaceutical giants were premier growth stocks throughout most of the 1990s. And despite current problems, the group stands to profit mightily from long-term increases in the demand for health care as the population ages. Nonetheless, over the past 18 months or so, the share prices of big drug companies have dropped as much as 57 percent, and most analysts have turned bearish on the group.
War, stock market blowouts, unemployment, terrorist alerts--there's no question that life in America has been stressful lately. Says Michael Faenza, ceo of the National Mental Health Association: "...
Wouldn't you know it. The Wall Street intelligentsia starts touting pharmaceutical stocks as a safe haven for tech-wrecked investors, and almost immediately big pharma gets into a fender bender of ...
When you arrive at the Indianapolis headquarters of Eli Lilly & Co., the $10.9-billion-a-year pharmaceuticals giant, you must pass through an elaborate airport-like security system before you're pe...
Inspiration is elusive. Innovation is hard. Demand for technical and conceptual breakthroughs in global business is intensifying. Organizations are looking everywhere for the transforming insight. ...
You might be suspicious of a single pill that reportedly helps treat depression, osteoarthritis, liver disease, multiple sclerosis, Parkinson's disease, and migraine headaches. You'd be even more s...
The death of nine-year-old Michael Adams-Conroy didn't seem at first like a signal event in medicine. It seemed like homicide.
On Aug. 9 a U.S. court of appeals handed down a hotly anticipated ruling: A pharmaceuticals company called Barr Labs would be allowed to sell a generic version of Eli Lilly's blockbuster antidepres...
A proposal for a brave new practice was recently smuggled into the Brave New Work e-mail box by an associate at one of the world's leading fictitious consulting firms.
Not that long ago, taking herbs and supplements other than a multivitamin was decidedly fringy. By 1999, supplements were a $14.7 billion industry, according to the Nutrition Business Journal, and ...
Steely Dan, Two Against Nature (Giant) After spending the past two decades in the "Where Are They Now?" bin, Donald Fagan and Walter Becker reel in the years for a sleek encore of funky Zen Pretzel...
Predicting the direction and pace of change in America is clearly not easy. Witness the unfortunate comments of Charles Duell, a former commissioner of the U.S. patent office. In 1899, on the cusp ...
Drug stocks have been stars of the 15-year bull market, with top names like Pfizer and Merck posting average annual gains of 24% since 1984 vs. 14.8% for the S&P 500. Several times during this peri...
On Dec. 7, Sepracor announced terrific news: Eli Lilly had agreed to pay up to $90 million, plus future royalties, for the Boston biotech's new and improved version of the legendary antidepressant ...
While most of Wall Street slouches toward the holiday season, at least one part of the biz--mergers and acquisitions--has held up pretty darn well. Yes, the real blockbuster deals--Citi-Travelers, ...
After studying psychiatry at Harvard in the 1960s, John W. Schott earned a stockbroker's license. Now the psychoanalyst and pioneer in the study of investor psychology is also a part-time portfolio...
Imagine, if you will, that you are an executive, lazily staring out the office window, when suddenly you spot your wife on the sidewalk in another guy's arms. But, staring more closely, you realize...
Good evening. Welcome to my laboratory.
It's been a bad day for your self-esteem: Your Prozac bottle's empty, the Rogaine isn't taking, and you've just found Viagra in your wife's Volvo. As you ponder this last development (Is it for you...
How far should a health insurer poke into your privacy? Deep enough to determine that you're depressed and maybe ought to go on Prozac? Lovelace Health Systems, a subsidiary of Cigna in Albuquerque...
Could your portfolio use a tonic? How about some of the world's biggest and brawniest pharmaceutical companies? Says Kurt von Emster, manager of the $150 million Franklin Global Health Care Fund: "...
ELI LILLY (LLY); NYSE, $61.50; 2.2% YIELD
Once upon a time, way back in the late 1980s, I considered myself hip. I had a sense of what was going on below 14th Street in Manhattan; I heard Lou Reed and John Cale sing a rock opera for Andy W...
THE MARCH of science has produced this arresting tidbit: Though most of us are in a blah or foul mood three days out of ten, an annoying 0.5% of the population is in a good mood all the time. And j...
ASKED HOW HE planned to put his two teenage sons through college, one 40-ish New York businessman offered this tongue-in-cheek reply: ''This is the age of self-sacrifice. I traded my BMW for a Chev...
If you believe the rich are indeed different, you'll love this novel strategy for trouncing the market: bet on the publicly traded companies the rich still control. That's the winning approach of t...
Tired of trying to forecast every little blip in the economy? Give yourself a break. George Yeager, president of Yeager Wood & Marshall, a New York City money management firm, does just fine by ign...
Take Two of Arthur Pancoe's Drug Stocks and You May Be Rich in the Morning.'' That headline ran above our November 1988 profile of Pancoe -- a prominent Bear Stearns broker in Chicago -- and turned...
Buy the best, avoid the rest, and never sell on bad news.'' By following this credo, veteran money manager Richard Cheswick, 66, benefited fully from the wartime stock rally that boosted the Dow 18...
TOUGHER CONSUMERS at home and millions of potential customers abroad make a good reputation more valuable than ever to U.S. companies. What does that reputation consist of? Every year more than 80%...
So far in 1990 the Dow is off more than 11%, corporate profits are sagging, and a lot of folks think the U.S. is in a recession or heading toward one. But some top-ranked investors don't find condi...
There's money in the brain's complexity. Twenty or so new biotech companies and giants like Eli Lilly and Hoffmann-La Roche are trying to cash in on neuroscience. By FORTUNE's estimate, the small f...
''The earnings momentum bottomed in the first quarter.'' So said Elaine Garzarelli, a portfolio manager for Shearson Lehman, as second-quarter earnings reports -- not all of them good -- began to c...
Health-care stocks have long ranked among Wall Street's hottest issues, and no wonder. Last year, Americans spent nearly $600 billion on medical care -- a staggering 12% of the gross national produ...
One of the few on Wall Street to sound a loud and clear alarm before Black Monday was Steven Einhorn, 39, co-chairman of the investment policy committee at Goldman Sachs. Late last summer he began ...
Before mulling over what he likes in a stock, Eliot Fried, 53, thinks about what he likes, and dislikes, about the economic outlook. ''Because I'm shooting at a stock price some months out,'' he sa...
THE VENDING MACHINE stood in the research ward, ready to dispense its goodies whenever someone had the urge for a snack. Half the food slots contained protein-rich fare: barbecued chicken wings, le...



